|
Title
|
|
|
|
miRNA-221 and miRNA-483-3p dysregulation in esophageal adenocarcinoma
| |
|
Author
|
|
|
|
| |
|
Abstract
|
|
|
|
| Alterations in microRNA (miRNA) expression have been reported in different cancers. We assessed the expression of 754 oncology-related miRNAs in esophageal adenocarcinoma (EAC) samples and evaluated their correlations with clinical parameters. We found that miR-221 and 483-3p were consistently upregulated in EAC patients vs. controls (Wilcoxon signed-rank test: miR-221 p < 0.0001; miR-483-3p p < 0.0001). Kaplan-Meier analysis showed worse cancer-related survival among all EAC patients expressing high miR-221 or miR-483-3p levels (log-rank p = 0.0025 and p = 0.0235, respectively). Higher miR-221 or miR-483-3p levels also correlated with advanced tumor stages (Mann-Whitney p = 0.0195 and p = 0.0085, respectively), and overexpression of miR-221 was associated with worse survival in low-risk EAC patients. Moreover, a significantly worse outcome was associated with the combined overexpression of miR-221 and miR-483-3p (log-rank p = 0.0410). To identify target genes affected by miRNA overexpression, we transfected the corresponding mimic RNA (miRVANA) for either miR-221 or miR-483-3p in a well-characterized esophageal adenocarcinoma cell line (OE19) and performed RNA-seq analysis. In the miRNA-overexpressing cells, we discovered a convergent dysregulation of genes linked to apoptosis, ATP synthesis, angiogenesis, and cancer progression, including a long non-coding RNA associated with oncogenesis, i.e., MALAT1. In conclusion, dysregulated miRNA expression, especially overexpression of miR-221 and 483-3p, was found in EAC samples. These alterations were connected with a lower cancer-specific patient survival, suggesting that these miRNAs could be useful for patient stratification and prognosis. |
| |
|
Language
|
|
|
|
English
| |
|
Source (journal)
|
|
|
|
Cancers
| |
|
Publication
|
|
|
|
2024
| |
|
ISSN
|
|
|
|
2072-6694
| |
|
DOI
|
|
|
|
10.3390/CANCERS16030591
| |
|
Volume/pages
|
|
|
|
16
:3
(2024)
, p. 1-16
| |
|
Article Reference
|
|
|
|
591
| |
|
ISI
|
|
|
|
001161127600001
| |
|
Pubmed ID
|
|
|
|
38339342
| |
|
Full text (Publisher's DOI)
|
|
|
|
| |
|
Full text (open access)
|
|
|
|
| |
|